M
Maarten J. Cramer
Researcher at Utrecht University
Publications - 249
Citations - 5861
Maarten J. Cramer is an academic researcher from Utrecht University. The author has contributed to research in topics: Heart failure & Cardiac resynchronization therapy. The author has an hindex of 38, co-authored 249 publications receiving 4803 citations. Previous affiliations of Maarten J. Cramer include VU University Medical Center & University Medical Center Utrecht.
Papers
More filters
Journal ArticleDOI
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study
Moniek G.P.J. Cox,Paul A. van der Zwaag,Christian van der Werf,Jasper J. van der Smagt,Maartje Noorman,Zahir A. Bhuiyan,Ans C.P. Wiesfeld,Paul G.A. Volders,Irene M. van Langen,Douwe E. Atsma,Dennis Dooijes,Arthur van den Wijngaard,Arjan C. Houweling,Jan D. H. Jongbloed,Luc Jordaens,Maarten J. Cramer,Pieter A. Doevendans,Jacques M.T. de Bakker,Arthur A.M. Wilde,J. Peter van Tintelen,Richard N.W. Hauer +20 more
TL;DR: In this article, the authors used multiplex ligation-dependent probe amplification to detect pathogenic mutations in genes encoding 5 desmosomal proteins in ARVD/C index patients.
Journal ArticleDOI
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population
Lotte Kaasenbrood,S. Matthijs Boekholdt,Yolanda van der Graaf,Kausik K. Ray,Ron J.G. Peters,John J.P. Kastelein,Pierre Amarenco,John C. LaRosa,Maarten J. Cramer,Jan Westerink,L. Jaap Kappelle,Gert J. de Borst,Frank L.J. Visseren +12 more
TL;DR: There is very substantial variation in estimated 10-year risk of recurrent vascular events in a secondary prevention population, suggesting that even with optimal treatment, many patients with vascular disease will remain at >20% and even >30% 10- year risk, clearly delineating an area of substantial unmet medical need.
Journal ArticleDOI
Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced.
Anneline S.J.M. te Riele,Anneline S.J.M. te Riele,Cynthia A. James,Binu Philips,Neda Rastegar,Aditya Bhonsale,Judith A. Groeneweg,Brittney Murray,Crystal Tichnell,Daniel P. Judge,Jeroen F. van der Heijden,Maarten J. Cramer,Birgitta K. Velthuis,David A. Bluemke,David A. Bluemke,Stefan L. Zimmerman,Ihab R. Kamel,Richard N.W. Hauer,Hugh Calkins,Harikrishna Tandri +19 more
TL;DR: The traditional description of the Triangle of dysplasia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) predates genetic testing and excludes biventricular phenotypes.
Journal ArticleDOI
Effect of Using the HEART Score in Patients With Chest Pain in the Emergency Department: A Stepped-Wedge, Cluster Randomized Trial.
Judith M. Poldervaart,Johannes B. Reitsma,Barbra E. Backus,Hendrik Koffijberg,Rolf F. Veldkamp,Monique E. ten Haaf,Yolande Appelman,Herman F.J. Mannaerts,Jan Melle van Dantzig,Madelon van den Heuvel,Mohamed el Farissi,Bernard J.W.M. Rensing,Nicolette M.S.K.J. Ernst,Ineke M.C. Dekker,Frank R. den Hartog,Thomas Oosterhof,Ghizelda R. Lagerweij,Eugene M. Buijs,Maarten W. J. van Hessen,Marcel A.J. Landman,Roland R.J. van Kimmenade,Luc Cozijnsen,Jeroen J.J. Bucx,Clara E.E. van Ofwegen-Hanekamp,Maarten J. Cramer,A. Jacob Six,Pieter A. Doevendans,Arno W. Hoes +27 more
TL;DR: The aim was to determine whether use of the HEART score results in reduced burden of care, hospitalizations, and health care costs but no increase in the occurrence of adverse cardiac events.
Journal ArticleDOI
Septal rebound stretch reflects the functional substrate to cardiac resynchronization therapy and predicts volumetric and neurohormonal response.
Bart W.L. De Boeck,Arco J. Teske,Mathias Meine,Geert E. Leenders,Maarten J. Cramer,Frits W. Prinzen,Pieter A. Doevendans +6 more
TL;DR: A novel myocardial deformation index that is highly sensitive to the effect of cardiac resynchronization therapy (CRT) and that can be used to predict response to CRT is developed.